Member Info for ratcliffewriter

Looks like it's around 23 to 25 centigrade with pretty much full sun in San Diego at the moment, which is nice. If they actually had a deal to sign then they'd just get on and sign it. As it is, this just looks to me like a repeat attempt at justifying yet another placing with the usual flurry of hope-raising RNSs for the faithful to chant about. Tick tock.....

'the share has historically been a poor investment for many' - what a classic! As an 'investment', i.e. something longer term it fits more in the category of 'unmitigated disaster.'

As a trading share it is probably at the riskier end of the scale for an experienced trader.

As for 'Reborn', I laughed so much the tears ran down my trouser leg.

If the usual cycle repeats once more, we're very close to the point where a new poster arrives, and in their first post tells the world that they've either just had this share tipped to them, or it was mentioned at lunch by Warren Buffet that Val is a unique opportunity with endless potential. That same poster is never heard from again.

Maybe that's one for next Monday or Tuesday, but if it's coming it will be soon.

Ok, so you think the placing will be after the end of May, and will do a victory lap when it arrives later than Porky's prediction. Fair enough - I think it will be April or a little later, but we just have to wait and see.

Notpot - out of interest, if the placing is before the end of this month will you say nothing on the morning of the RNS and just disappear for a few weeks before starting the usual pumping yet again?

Or if the placing actually doesn't take place until later in the spring will you feel some sense of vindication and 'victory' as a consequence?

That post sounds like the Fast Show football pundit sketch, but a lot funnier.

‘…he sold defender VAL401 for a lucrative £16m plus royalties to Ambrose’ – the RNS actually says ‘up to £16 million plus royalties’, and then goes on to say ‘The initial £6 million milestones are payable in cash or the equivalent value in new ordinary shares in Ambrose with the issue price determined by the latest issue of shares in Ambrose, at the discretion of Ambrose. Payment of milestones in cash is subject to Ambrose raising capital in due course.’

First thing of note there – incoming money will be ‘cash or equivalent value in new ordinary shares in Ambrose’, a company with declared capital and reserves of £26,741 in its most recent accounts. (Down from 164,643 the previous year) So how they would be able to give away 6 million pounds in shares is a mystery.

Second thing of note – ‘Payment in cash is subject to Ambrose raising capital in due course.’ Since that RNS nine months ago, Ambrose appears to have raised…nothing. And what declared progress has taken place around 401? None, apparently.

However it isn’t all gloom and doom – 401 belongs to Valiseek. Companies House lists three active directors for Valiseek, number one being Suzanne Dilly. What can possibly go wrong?

Meanwhile the clock ticks, the salaries get paid, and the coffers run dry.

Signs of a new 'big push' are pretty conspicuous imo - last year there seemed to be a convenient bout of RNSs which had little of any substance when read with any care, but which raised hopes and not cash ahead of the late-year placing. Now we've had a few similar efforts pop up in quick succession lately which raises suspicions among a few here of a repeat coming.

Let's hope any potential 'new money' coming in is able to see the bigger picture in the history as a caveat.

As for 'he too was considerably underwater on his appointment. His stated objective was simple: to ensure the company becomes self-financing and then profitable. 18 months down the line, he is on the cusp of making that reality' - how about a little more detail - 'he too was considerably underwater on his appointment' (and remains way way further underwater now. The sp was 2.45p on the day of his announcement as CEO. It needs to rise by some 800 percent or so to reach that price again.)

'His stated objective was simple: to ensure the company becomes self-financing and then profitable.' - well that's an innovative and creative ambition for anyone not running a nationalised enterprise - but 18 months down the line, he is apparently no nearer making that a reality. He does however receive a large salary, none of it in shares in lieu of pay, which will cushion the blow of any loss of value in his shares, a luxury not afforded to other shareholders.'

A little more detail often helps for a better understanding I feel.

Looks like the 'big push' has started in the final approach to the next placing.

I wonder if any news will be filtered or full strength...

I was thinking exactly the same Ray. But then I would/we do/we are.

Hey ho....

I doubt it is that the CEO has no intention of selling I'd imagine that with the sp still in the lower .30s and looking weak, he simply cannot sell even a single share without causing a catastrophic price crash. His buying has caused no upward movement, so any hint of him selling would cause the next placing to fail I suspect.

Presumably at a tobacco industry conference they do all the serious meetings over a crafty cig by the bike sheds at the back of the hall.

A '4-star quantitative star rating'? OK, if that's not a pure ramp, please give us an example of a company with a one star rating......because if a company qualifies for four stars in the state Valirx is in, a one star business must be something less successful than a tramp asking for '10p for a cup of tea.'

Unless it's a star rating that goes up to a thousand or more of course.

He'll get all his outlay back and then some in next month's pay cheque. Not something any other investor gets from Val.

Anyway, that's two pump RNSs in 2 days. Maybe a couple more next week or the sp may well drop below .30 once more.

The only reason Val is still in existence is because of people (not institutions) opening their wallets at each of the numerous placings - whether those people are traders or chancers is open to debate, but one thing for sure is that anyone who was by the 'commercial potential' of the science will be badly out of pocket, and regretting that they ever listened to some of the core cheerleaders here.

In his glowing summary of significant bullet points over the past year, PP seems to have omitted the latest placing which took place at a walloping discount because no institutional investor wanted to put money in. Easy to overlook a minor detail like a placing though - there have been so many they have become part of the scenery.

*'almost as much'...

Nomlungu - I trust you had time to see my reply before it was removed. That in itself says almost as about the ramp gang as their silence here this morning does.

The earlier 13.51 trades were sells, but after a certain point in the day the bid dropped to 13.4 for lesser amounts and 13.15 for big quantities, so after that point 13.50 on six figure numbers of shares is going to be a buy imo.

I agree with the comparison with El Dorado - it seems entirely appropriate to me.

El Dorado was a mythical city of gold, hunted for by many at vast expense and loss of life, but ultimately turned out to be a story pushed by greedy fantasists but disproved by facts.